Journal of Neuro-Oncology

, Volume 43, Issue 3, pp 199–201 | Cite as

Epidemiology of Primary CNS Lymphoma

  • Martin Schabet


In the beginning of the nineties the National Cancer Institute Surveillance, Epidemiology, and End Results Program calculated the incidence of primary central nervous system non-Hodgkin's lymphoma (PCNSL) as 1:100 000. The incidence of PCNSL has been increasing since the seventies in immunocompetent patients. The main increase, however, is taking place since the mid-eighties and is due to the increase of immunodeficieny and immunosuppression. The risk is 2–6% in AIDS patients according to clinical data and will probably further increase with the length of survival in these patients. Transplant patients carry a risk of 1–5% to develop a PCNSL. The risk is 1–2% for renal, and 2–7% for cardiac, lung or liver transplant recipients. Patients with congenital immune deficiency have a risk of 4%. PCNSL may also present as a secondary malignancy.

epidemiology non-Hodgkin's lymphoma primary CNS lymphoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jellinger KA, Paulus W: Primary central nervous system lymphomas-new pathological developments. J Neuro-Oncol 24: 33–36, 1995Google Scholar
  2. 2.
    Eby NL, Gruffermann S, Flannelly CM, Schold SC, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461–2465, 1988PubMedGoogle Scholar
  3. 3.
    Ahsan H, Neugut AI, Bruce JN: Trends in the incidence of primary malignant brain tumors in USA, 1981–1990. Int J Epidemiol 24: 1078–1085, 1995PubMedGoogle Scholar
  4. 4.
    Ferracini R, Pileri S, Bergmann M, Sabattini E, Rigobello L, Gambacorta M, Galli C, Manetto V, Frank G, Godano U, Spagnolli F, Casadei G, Azzolini U, Falini B, Gullotta F: Non-Hodgkin's lymphomas of the central nervous system. Pathol Res Pract 189: 249–260, 1993PubMedGoogle Scholar
  5. 5.
    Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835–853, 1988Google Scholar
  6. 6.
    O'Neill BP, Tomlinson FH, O'Falloon, Scheithauer BW, Kurtin PJ, O'Neill DB: The continuing increase of primary central nervous system non-Hodgkin's lymphoma (abstract). Ann Neurol 34: 313, 1993Google Scholar
  7. 7.
    O'Sullivan MG, Whittle IR, Gregor A, IronsideJW: Increasing incidence of CNS primary lymphoma in south-east Scotland (letter). Lancet 338: 895–896, 1991PubMedGoogle Scholar
  8. 8.
    Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodefi-ciency syndrome. J Neurosurg 73: 206–211, 1990PubMedGoogle Scholar
  9. 9.
    Ling SM, Roach M, Larson DA, Wara WM: Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco. Cancer 73: 2570–2582, 1994PubMedGoogle Scholar
  10. 10.
    Penn I, Porat G: Central nervous system lymphomas in organ allograft recipients. Transplantation 59: 240–244, 1995PubMedGoogle Scholar
  11. 11.
    Fine H, Mayer R: Primary central nervous system lymphomas. Ann Intern Med 119: 1093–1104, 1993PubMedGoogle Scholar
  12. 12.
    Reni M, Ferreri AJM, Garancini MP, Villa E: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 227–234, 1997PubMedGoogle Scholar
  13. 13.
    Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, BoswellW, Petrovich Z, Chak L, Levine AM: Primary central nervous system lymphoma in AIDS. Cancer 63: 1101–1107, 1989PubMedGoogle Scholar
  14. 14.
    Levy RM, Janssen RS, Bush TJ, Rosenblum ML: Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1: 31–40, 1988PubMedGoogle Scholar
  15. 15.
    Rosenblum ML, Levy RM, Bredesen DE, So YT, Wara W, Ziegler JL: Primary central nervous system lymphomas in patients with AIDS. Ann Neurol 23: S13–S16, 1988PubMedGoogle Scholar
  16. 16.
    MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: 969–973, 1991PubMedGoogle Scholar
  17. 17.
    Goplen AK, Dunlop O, Liestol K, Lingjaerde OC, Bruun JN, Maehlen J: The impact of primary central nervous system lymphoma in AIDS patients: a population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Hum Retrovirol 14: 351–354, 1997PubMedGoogle Scholar
  18. 18.
    Patchell RA: Primary central nervous system lymphoma in the transplant patient. Neurol Clin 6: 297–303, 1988PubMedGoogle Scholar
  19. 19.
    Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B: Incidence and consequences of posttransplantation lymphoproliferative disorders. J Nephrol 10: 136–145, 1997PubMedGoogle Scholar
  20. 20.
    Penn I: Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12: S328–S336, 1993PubMedGoogle Scholar
  21. 21.
    Penn I: Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 2: 52–59, 1996PubMedGoogle Scholar
  22. 22.
    Filipovich AH, Heinitz KJ, Robison LL, Frizzera G: The Immunodeficiency Cancer Registry. A research resource. Am J Pediatr Hematol Oncol 9: 183–184, 1987PubMedGoogle Scholar
  23. 23.
    Perry GS 3rd, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, KrivitW, Kersey JH: TheWiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97: 72–78, 1980PubMedGoogle Scholar
  24. 24.
    Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G: Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 46: 1607–1612, 1996PubMedGoogle Scholar
  25. 25.
    Kinlen LJ: Incidence of cancer in rheumatoid arthritis and other immunosuppressive treatment. Am J Med 78: 44–49, 1985Google Scholar
  26. 26.
    DeAngelis LM: Primary central nervous system lymphoma as a secondary malignancy. Cancer 67: 1431–1435, 1991PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Martin Schabet
    • 1
  1. 1.Department of NeurologyUniversity of TuebingenGermany

Personalised recommendations